Company information
- Ticker
- TLRY
- Country
- United States
- Sector
- Health Care
- Industry
- Pharma
Tilray Brands Business Summary
Tilray Brands, Inc. (TLRY) operates as a global consumer packaged goods (CPG) and lifestyle company, generating revenue through a diversified four-pillar business model: Cannabis, Beverage Alcohol, Distribution, and Wellness. As of February 2026, the company maintains its position as the top-ranked producer in Canadian adult-use cannabis and European medical cannabis, while solidifying its status as the fifth-largest craft brewer in the United States. Revenue streams are balanced across the wholesale and retail sale of cannabis, pharmaceutical distribution via its CC Pharma subsidiary, and a growing portfolio of craft spirits and hemp-based foods under the Manitoba Harvest brand. Tilray competes directly with Canopy Growth Corporation, Aurora Cannabis, Cronos Group, and SNDL Inc., positioning itself as a diversified CPG powerhouse rather than a pure-play cannabis cultivator to hedge against regional regulatory shifts. The executive leadership is led by Chairman and CEO Irwin D. Simon, a transformative entrepreneur who previously founded and scaled The Hain Celestial Group into a multi-billion dollar organic products leader. The core management team, largely comprising former Aphria Inc. executives following the 2021 merger, includes Chief Financial Officer Carl Merton and Chief Strategy Officer Denise Faltischek, both of whom possess deep expertise in international M&A and CPG operations. While the company was originally founded by Brendan Kennedy and the Privateer Holdings team, the current leadership reflects a pivot toward institutional CPG management. The board is supported by notable figures such as Vice-Chair Renah Persofsky and David Hopkinson, focusing on global scalability and the integration of the company's extensive beverage and wellness assets.